4.5 Article

Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Biodegradable nanogels for oral delivery of interferon for norovirus infection

Yunjeong Kim et al.

ANTIVIRAL RESEARCH (2011)

Article Pharmacology & Pharmacy

Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis

Wang Ya-Feng et al.

ANTIVIRAL RESEARCH (2009)

Review Cardiac & Cardiovascular Systems

Acute viral myocarditis

Robert Dennert et al.

EUROPEAN HEART JOURNAL (2008)

Article Biotechnology & Applied Microbiology

A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum

M. L. Reyes Escogido et al.

BIOTECHNOLOGY LETTERS (2007)

Article Cardiac & Cardiovascular Systems

Antiviral and myocyte protective effects of murine interferon-β and -α2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice

Yi-Xin Wang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

Mx1 and IP-10:: Biomarkers to measure IFN-β activity in mice following gene-based delivery

Harald Petry et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)

Article Biochemical Research Methods

Virus free, cell-based assay for the quantification of murine type I interferons

M Bollati-Fogolín et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2005)

Article Cardiac & Cardiovascular Systems

Protective role for interferon-β in coxsackievirus B3 infection

R Deonarain et al.

CIRCULATION (2004)